Cancer Genetics, Inc.
(NASDAQ : CGIX)

( )
CGIX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita HealthCare Partners Inc.
2.33%63.302.3%$199.19m
CHEChemed Corporation
-0.52%419.5510.1%$46.69m
AMEDAmedisys, Inc.
-1.37%130.9311.6%$28.68m
ACHCAcadia Healthcare Company, Inc.
2.57%32.7927.2%$26.95m
LHCGLHC Group, Inc.
0.68%118.412.9%$21.13m
ADUSAddus HomeCare Corporation
-0.95%77.361.2%$18.13m
MDMEDNAX, Inc.
1.78%23.9711.3%$17.17m
NEONeoGenomics, Inc.
1.26%21.636.1%$15.05m
USPHU.S. Physical Therapy, Inc.
1.89%133.144.8%$11.38m
ENSGEnsign Group, Inc.
2.06%49.515.8%$10.56m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
0.49%34.920.1%$5.26m
RDNTRadNet, Inc.
0.53%15.210.5%$3.56m
COChina Cord Blood Corporation
4.57%4.580.3%$0.61m
PDEXPro-Dex, Inc.
0.52%15.460.1%$0.35m
VNRXVolitionrx Limited
-2.24%3.920.6%$0.21m

Company Profile

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.